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Figure: Pilot data shows increased levels of methylation 
seen in pre invasive and invasive cancer in chronic UC .
Rationale for Study
• Introduction
•  Ulcerative Colitis (UC) is an aggressive and incurable     
inflammatory bowel disease that affects young people 
typically in their teens and early twenties. 
• Patients with chronic UC are at an increased risk of developing 
colorectal cancer. 
• Current surveillance strategies miss up to half of cancers in 
this young population.2 
• Methylation biomarkers may enable early detection of high 
risk individuals before the onset of cancer (neoplasia). 
Hypothesis
Aberrant methylation of Wnt genes in chronically 
inflamed mucosa in UC predates clinically detectable 
neoplasia and this can be exploited to stratify cancer 
risk.
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A nested matched case-controlled study will be performed using 
archived FFPE biopsies from a cohort of patients with UC who 
have been under surveillance for at least three episodes (6  - 8 
years).
•Cases have been selected where cancer or dysplasia has been 
identified following two or more negative surveillance episodes.
•Controls have been drawn from patients who remained free of 
disease after a period of follow-up similar to that at which the 
matched case is diagnosed with cancer or dysplasia.  These will 
be matched for duration of disease, the number of negative 
surveillance episodes, age and gender. Two controls have been 
identified for each case.
•All tissue extracted from controls and cases will be examined 
for the presence of methylated markers from our panel of Wnt 
genes. 
•55 cases (110) controls having been identified will be analysed 
in a nested case-control study
•For a gene that is hypermethylated in 50% of patients with CAN 
and 5% of controls, this will have at least 80% power to detect a 
10-fold increased risk of progression to neoplasia associated 
with hypermethylation.
What is the Clinical potential of this research?
•The delivery and evaluation of a DNA based test that will 
enhance the detection of colitis associated neoplasia before 
invasive malignancy has developed.
•The potential, in the future, to target novel chemoprevention 
agents at an identifiable high risk population.
Proposal
Methylation analysis of a 73 year old female with chronic colitis
Pilot data looks promising!
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Can methylation markers prevent cancer 
progression in UC? 
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